glp-1 receptor agonist creatine interaction How & Support Muscle Growth Creatine and Tirzepatide Interaction: Safety
Description
The GIPR/GLP-1R/GCGR tri-agonist LY3437943 has been compared with dulaglutide 1.5 mg and placebo in a Phase I study in individuals with type 2 diabetes [51]
Different drug classes, different side effect profiles, different durations of use
[DOI] [PubMed] [Google Scholar] 902.Dungan K.M., Povedano S.T., Forst T., Gonzalez J.G., Atisso C., Sealls W
Pricing Disclaimer: All pricing and availability information reflects company disclosures at the time of publication (January 2026) and is subject to change without notice
